Hand, Foot and Mouth Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a randomized controlled trial
We describe the protocol for a randomized, placebo-controlled, double-blind trial of intravenous MgSO4 in Vietnamese children diagnosed clinically with HFMD plus ANS dysregulation with systemic hypertension. A loading dose of MgSO4 or identical placebo is given over 20 min followed by a maintenance infusion for 72 h according to response, aiming for Mg levels two to three times the normal level in the treatment arm. The primary endpoint is a composite of disease progression within 72 h defined as follows: development of pre-specified blood pressure criteria necessitating the addition of milrinone, the need for ventilati...
Source: Trials - February 19, 2016 Category: Research Source Type: clinical trials
Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease
Condition: Handfoot-mouth DiseaseInterventions: Drug: Ribavirin plus Xiao'er jiebiao oral liquid; Drug: RibavirinSponsors: Children's Hospital of Fudan University; Weihai Rensheng PharmacyRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2014 Category: Research Source Type: clinical trials
Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in Vietnam
Condition: Hand, Foot and Mouth DiseaseInterventions: Drug: Magnesium Sulphate; Drug: Sterile waterSponsors: Oxford University Clinical Research Unit, Vietnam; Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam; Children's Hospital 1, Ho Chi Minh City, Viet NamRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2013 Category: Research Source Type: clinical trials
Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71
Condition: Hand, Foot and Mouth DiseaseInterventions: Biological: INV21 Low Dose; Biological: INV21 High Dose; Biological: PlaceboSponsor: Inviragen Inc.Completed - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2011 Category: Research Source Type: clinical trials